These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 16775331)

  • 1. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
    Hartman AL; Dover JE; Towner JS; Nichol ST
    J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus.
    Hartman AL; Bird BH; Towner JS; Antoniadou ZA; Zaki SR; Nichol ST
    J Virol; 2008 Mar; 82(6):2699-704. PubMed ID: 18199658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus.
    Hartman AL; Towner JS; Nichol ST
    Virology; 2004 Oct; 328(2):177-84. PubMed ID: 15464838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire.
    Boehmann Y; Enterlein S; Randolf A; Mühlberger E
    Virology; 2005 Feb; 332(1):406-17. PubMed ID: 15661171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.
    Basler CF; Mikulasova A; Martinez-Sobrido L; Paragas J; Mühlberger E; Bray M; Klenk HD; Palese P; García-Sastre A
    J Virol; 2003 Jul; 77(14):7945-56. PubMed ID: 12829834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice.
    Kiyotani K; Sakaguchi T; Kato A; Nagai Y; Yoshida T
    Virology; 2007 Mar; 359(1):82-91. PubMed ID: 17027894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.
    Hoenen T; Groseth A; Kolesnikova L; Theriault S; Ebihara H; Hartlieb B; Bamberg S; Feldmann H; Ströher U; Becker S
    J Virol; 2006 Jul; 80(14):7260-4. PubMed ID: 16809331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.
    Ledgerwood JE; Costner P; Desai N; Holman L; Enama ME; Yamshchikov G; Mulangu S; Hu Z; Andrews CA; Sheets RA; Koup RA; Roederer M; Bailer R; Mascola JR; Pau MG; Sullivan NJ; Goudsmit J; Nabel GJ; Graham BS;
    Vaccine; 2010 Dec; 29(2):304-13. PubMed ID: 21034824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evasion of interferon responses by Ebola and Marburg viruses.
    Basler CF; Amarasinghe GK
    J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.
    Lefort S; Soucy-Faulkner A; Grandvaux N; Flamand L
    J Virol; 2007 Oct; 81(20):10950-60. PubMed ID: 17652396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening.
    Towner JS; Paragas J; Dover JE; Gupta M; Goldsmith CS; Huggins JW; Nichol ST
    Virology; 2005 Feb; 332(1):20-7. PubMed ID: 15661137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.
    Hartman AL; Ling L; Nichol ST; Hibberd ML
    J Virol; 2008 Jun; 82(11):5348-58. PubMed ID: 18353943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations within the human parainfluenza virus type 3 (HPIV 3) C protein affect viral replication and host interferon induction.
    Wells G; Addington-Hall M; Malur AG
    Virus Res; 2012 Aug; 167(2):385-90. PubMed ID: 22634035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
    Fanunza E; Frau A; Corona A; Tramontano E
    Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3.
    Hato SV; Ricour C; Schulte BM; Lanke KH; de Bruijni M; Zoll J; Melchers WJ; Michiels T; van Kuppeveld FJ
    Cell Microbiol; 2007 Dec; 9(12):2921-30. PubMed ID: 17991048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.
    Enterlein S; Warfield KL; Swenson DL; Stein DA; Smith JL; Gamble CS; Kroeker AD; Iversen PL; Bavari S; Mühlberger E
    Antimicrob Agents Chemother; 2006 Mar; 50(3):984-93. PubMed ID: 16495261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation.
    Donelan NR; Dauber B; Wang X; Basler CF; Wolff T; García-Sastre A
    J Virol; 2004 Nov; 78(21):11574-82. PubMed ID: 15479798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of Ebola virus from cDNA using heterologous support proteins.
    Theriault S; Groseth A; Neumann G; Kawaoka Y; Feldmann H
    Virus Res; 2004 Nov; 106(1):43-50. PubMed ID: 15522446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35-Associated Inhibition of Double-Stranded RNA-Stimulated, Retinoic Acid-Inducible Gene 1-Mediated Induction of Interferon β.
    Cannas V; Daino GL; Corona A; Esposito F; Tramontano E
    J Infect Dis; 2015 Oct; 212 Suppl 2():S277-81. PubMed ID: 25926684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebola virus defective interfering particles and persistent infection.
    Calain P; Monroe MC; Nichol ST
    Virology; 1999 Sep; 262(1):114-28. PubMed ID: 10489346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.